VUS Genetics is supporting drug target development and patient stratification in oncology and for rare genetic diseases. Our mission is to help bring personalised treatment approaches to patients. We do this by designing CRISPR based functional assays that address the mechanism underlying the disease biology or drug response. Using such functional assays, we help drug developers identify the patients for whom their precision medicine can reverse disease pathology, or provide more specific cancer treatments. In addition to our gene editing expertise, we also offer expertise in DDR oncology and rare genetic diseases, including lysosomal storage diseases. Collaborative culture and mechanistic insight are close to our heart, and we aim to continue innovating both on our disease understanding and gene editing approaches.
Company Details
- Employees
- 12
- Address
- Stadionweg 188, 3,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.vusgenetics.com/
- HQ
- Amsterdam, North Holland
Vus Genetics Questions
Vus Genetics's website is https://www.vusgenetics.com/
Vus Genetics's LinkedIn profile is https://nl.linkedin.com/company/vus-genetics
Vus Genetics has
12 employees.
View email and phone details for 12
employees at Vus Genetics.
Vus Genetics's industry is
Biotechnology Research
Vus Genetics's top competitors are
Vivalyx,
Simon Grund Aps,
Code Ocean,
Rapidemic,
Leyden Labs,
Uniqure,
Vectory,
Imuno Therapeutics,
Alamya Health,
Caszyme.
Vus Genetics's categories are Biotechnology Research
